Khosla Ventures Acquisition Co. II (KVSB) Prices $400M IPO
by Nicholas Alan Clayton on 2021-03-24 at 12:30pm

Khosla Ventures Acquisition Co. II announced the pricing of its $400 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “KVSB”, Wednesday, March 24.

The new company aims to combine with a high-quality growth target addressing large markets with proprietary technology. Khosla II is led by founder Vinod Khosla, CEO Samir Kaul and COO, CFO, Treasurer and Secretary Peter Buckland.

Total SPAC deal count for 2021 year-to-date is now 293. This offering is expected to close on Friday, March 26.


Citigroup Global Markets Inc. and Goldman Sachs & Co. LLC are serving as the book-running manager for this offering. Latham & Watkins LLP is serving as Issuer’s Counsel with Skadden, Arps, Slate, Meagher & Flom LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.

Recent Posts
by Nicholas Alan Clayton on 2024-12-24 at 2:07pm

Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...

by Nicholas Alan Clayton on 2024-12-24 at 8:13am

At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...

by Nicholas Alan Clayton on 2024-12-23 at 3:40pm

Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...

by Kristi Marvin on 2024-12-23 at 10:52am

Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that...

by Nicholas Alan Clayton on 2024-12-23 at 8:18am

At the SPAC of Dawn SPACs have set to have a busy holiday week with three business combination approval votes and eight special meetings for extensions. Teams are trying to get eight of these in the books today, including all three completion votes ahead of Christmas Eve tomorrow. As noted last week, the theme of...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved